Peter D. Kies

Peter D. Kies

Chief Financial OfficeratInovio Pharmaceuticals· In proxies 2022–2025

Pay in FY2025-11% from the year before · Inovio Pharmaceuticals stock -4.9% the same year

Peter D. Kies was paid $833.7K in FY2025 (Dec), down 11%. Inovio Pharmaceuticals stock fell 4.9% that year.

Pay$100 in the stock at the end of FY21 → $3
Pay is from the Summary Compensation Table of each Inovio Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inovio PharmaceuticalsPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role -99%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?